MXPA02010039A - Procedimiento para la obtencion de derivados de 1[[piridil sustituido)metil]tio]bencimidazol. - Google Patents

Procedimiento para la obtencion de derivados de 1[[piridil sustituido)metil]tio]bencimidazol.

Info

Publication number
MXPA02010039A
MXPA02010039A MXPA02010039A MXPA02010039A MXPA02010039A MX PA02010039 A MXPA02010039 A MX PA02010039A MX PA02010039 A MXPA02010039 A MX PA02010039A MX PA02010039 A MXPA02010039 A MX PA02010039A MX PA02010039 A MXPA02010039 A MX PA02010039A
Authority
MX
Mexico
Prior art keywords
benzimidazol
thio
methyl
alkoxy
carbon atoms
Prior art date
Application number
MXPA02010039A
Other languages
English (en)
Inventor
Maimo Ramon Berenguer
Original Assignee
Esteve Quimica Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Quimica Sa filed Critical Esteve Quimica Sa
Publication of MXPA02010039A publication Critical patent/MXPA02010039A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)

Abstract

El procedimiento para la obtencion de derivados de [[(piridil sustituido)metil]tio]bencimidazol (l), donde cada uno de R1, R3 y R4, independientemente entre si, es hidrogeno, alquilo, alcoxi o alcoxi fluorado de 1 a 6 atomos de carbono, y R2 es nitro, halogeno, alcoxi o alcoxi halogenado de 1 a 6 atomos de carbono, o un grupo -O-(CH2)n-OR8, donde n es un numero entero comprendido entre 1 y 6, y R8 representa hidrogeno o un grupo alquilo de 1 a 6 atomos de carbono, comprende (a) hacer reaccionar un N- oxido de una metilpiridina con un anhidrido de acido carboxilico activado o de acido sulfonico, y (b) hacer reaccionar el intermedio formado en la etapa (a) con un mercaptobencimidazol correspondiente. Los compuestos (I) son utiles para sintetizar derivados de [[(piridil sustituido)metil]sulfinil]bencimidazol, como por ejemplo omeprazol, lansoprazol, rabeprazol o pantoprazol. (ver formula).
MXPA02010039A 2000-04-14 2001-04-10 Procedimiento para la obtencion de derivados de 1[[piridil sustituido)metil]tio]bencimidazol. MXPA02010039A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200000989A ES2171116B1 (es) 2000-04-14 2000-04-14 Procedimiento para la obtencion de derivados de (((piridil sustituido)metil)tio)bencimidazol.
PCT/ES2001/000143 WO2001079194A1 (es) 2000-04-14 2001-04-10 Procedimiento para la obtención de derivados de [[(piridil sustituido)metil]tio]bencimidazol

Publications (1)

Publication Number Publication Date
MXPA02010039A true MXPA02010039A (es) 2004-08-19

Family

ID=8493207

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02010039A MXPA02010039A (es) 2000-04-14 2001-04-10 Procedimiento para la obtencion de derivados de 1[[piridil sustituido)metil]tio]bencimidazol.

Country Status (18)

Country Link
US (1) US6723852B2 (es)
EP (1) EP1411053B1 (es)
JP (1) JP2003531144A (es)
KR (1) KR100757346B1 (es)
CN (1) CN1214027C (es)
AT (1) ATE363479T1 (es)
AU (1) AU780314B2 (es)
CA (1) CA2405304C (es)
CY (1) CY1106632T1 (es)
DE (1) DE60128736T2 (es)
DK (1) DK1411053T3 (es)
ES (2) ES2171116B1 (es)
HU (1) HUP0300583A2 (es)
MX (1) MXPA02010039A (es)
NO (1) NO323468B1 (es)
NZ (1) NZ521930A (es)
PT (1) PT1411053E (es)
WO (1) WO2001079194A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2185459B1 (es) * 2000-10-02 2003-12-16 Dinamite Dipharma Spa Procedimiento para la obtencion de pantoprazol y compuestos intermedios para el mismo.
WO2004056804A2 (en) * 2002-12-19 2004-07-08 Teva Pharmaceutical Industries Ltd. Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates
ES2245277T1 (es) * 2003-03-12 2006-01-01 Teva Pharmaceutical Industries Limited Solidos cristalinos y amorfos de pantoprazol y procedimientos para su preparacion.
US7683177B2 (en) * 2003-06-10 2010-03-23 Teva Pharmaceutical Industries Ltd Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazole
ITMI20031813A1 (it) * 2003-09-23 2005-03-24 Dinamite Dipharma S P A In Forma A Bbreviata Diph Procedimento per la preparazione di pantoprazolo e suoi sali.
KR100771659B1 (ko) * 2005-03-23 2007-10-30 주식회사 카이로제닉스 판토프라졸 및 그 중간체의 제조방법
EP1893602A2 (en) * 2005-05-06 2008-03-05 Medichem, S.A. Pantoprazole free acid form iii
US20090143438A1 (en) * 2006-03-10 2009-06-04 Arigen Pharmaceuticals, Inc. Novel Pyridine Derivative Having Anti-Helicobacter Pylori Activity
WO2008001392A2 (en) * 2006-06-30 2008-01-03 Msn Laboratories Limited An improved process for the preparation of pantoprazole and its pharmaceutically acceptable salts
PT2103608E (pt) 2006-12-18 2012-09-24 Arigen Pharmaceuticals Inc Agente de erradicação de helicobacter pylori possuindo uma actividade inibidora na secreção de ácido gástrico
EP2181106A1 (en) 2007-07-17 2010-05-05 Ranbaxy Laboratories Limited Process for the preparation op pantoprazole sodium and pantoprazole sodium sesquihydrate
US20090076089A1 (en) * 2007-09-17 2009-03-19 Protia, Llc Deuterium-enriched pantoprazole
CN102020637B (zh) * 2010-12-13 2014-09-10 浙江华义医药有限公司 5-二氟甲氧基-2-[[(3,4-二甲氧基-2-吡啶基)甲基]硫基]-1h-苯并咪唑制备法
CN103242297A (zh) * 2013-05-20 2013-08-14 湖北宜恒茶油产业科技有限责任公司 一种5-二氟甲氧基-2-[[(4-氯-3-甲氧基-2-吡啶基)甲基]硫代]-1h-苯并咪唑一水合物的制备方法
CN103664886A (zh) * 2013-12-06 2014-03-26 威海迪素制药有限公司 2-[[[4-(3-甲氧基丙氧基)-3-甲基吡啶-2-基]甲基]硫代]-1h-苯并咪唑的制备方法
CN105399729B (zh) * 2015-12-21 2018-04-17 山东金城医药化工有限公司 奥美拉唑的合成方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8204879D0 (sv) * 1982-08-26 1982-08-26 Haessle Ab Novel chemical intermediates
HU195220B (en) * 1983-05-03 1988-04-28 Byk Gulden Lomberg Chem Fqb Process for production of new fluor-alkoxi-benzimidasole-derivatives and medical compositions containig them
ZA854287B (en) * 1984-06-16 1986-02-26 Byk Gulden Lomberg Chem Fab Dialkoxypyridines,process for their preparation,their use and medicaments containing them
JPS6150978A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
FR2593178B1 (fr) * 1986-01-20 1988-04-29 Esteve Labor Dr Derives de 2-benzimidazolylalkylthio (ou sulfinyle ou sulfonyle) leur preparation et leur application en tant que medicaments.
JPH0674272B2 (ja) * 1986-11-13 1994-09-21 エーザイ株式会社 ピリジン誘導体及びそれを含有する潰瘍治療剤
ES2026761A6 (es) * 1990-10-31 1992-05-01 Genesis Para La Investigacion Procedimiento de obtencion del omeprazol.
ES2024357A6 (es) * 1990-12-05 1992-02-16 Genesis Para La Investigacion Procedimiento de obtencion de halohidrato de 2-halometil-3,5-dimetil-4-metoxipiri-dina.
ES2036948B1 (es) * 1991-11-21 1994-09-01 Genesis Para La Investigacion Procedimiento de obtencion de compuestos derivados de piridina.
WO1995011897A1 (fr) * 1993-10-29 1995-05-04 Yoshitomi Pharmaceutical Industries, Ltd. Compose de pyridine et son utilisation en tant que remede
JP3828648B2 (ja) * 1996-11-14 2006-10-04 武田薬品工業株式会社 ２−（２−ピリジルメチルスルフィニル）ベンズイミダゾール系化合物の結晶およびその製造法
ID18983A (id) * 1996-12-04 1998-05-28 Lilly Co Eli Pirazola sebagai inhibitor sekresi fosfolipase a2 non-pankreas pada manusia
GB9921578D0 (en) * 1999-09-13 1999-11-17 Cipla Limited Omeprazole synthesis

Also Published As

Publication number Publication date
US6723852B2 (en) 2004-04-20
HUP0300583A2 (hu) 2003-07-28
ES2284629T3 (es) 2007-11-16
US20030036656A1 (en) 2003-02-20
CN1427836A (zh) 2003-07-02
ATE363479T1 (de) 2007-06-15
ES2171116B1 (es) 2003-08-01
NO323468B1 (no) 2007-05-21
KR20030030990A (ko) 2003-04-18
JP2003531144A (ja) 2003-10-21
CN1214027C (zh) 2005-08-10
CA2405304C (en) 2011-01-18
CY1106632T1 (el) 2012-01-25
DE60128736D1 (de) 2007-07-12
CA2405304A1 (en) 2002-10-07
KR100757346B1 (ko) 2007-09-11
AU780314B2 (en) 2005-03-17
NO20024858D0 (no) 2002-10-08
DE60128736T2 (de) 2008-02-07
NO20024858L (no) 2002-12-06
WO2001079194A1 (es) 2001-10-25
DK1411053T3 (da) 2007-09-24
PT1411053E (pt) 2007-07-12
EP1411053B1 (en) 2007-05-30
ES2171116A1 (es) 2002-08-16
EP1411053A1 (en) 2004-04-21
NZ521930A (en) 2004-07-30
WO2001079194A9 (es) 2003-05-08
AU4655101A (en) 2001-10-30

Similar Documents

Publication Publication Date Title
MXPA02010039A (es) Procedimiento para la obtencion de derivados de 1[[piridil sustituido)metil]tio]bencimidazol.
EE05402B1 (et) Meetod bensimidasooli-tüüpi ühendite valmistamiseks ning k?rvalsaadusena moodustunud sulfoonide eemaldamiseks
HK1123985A1 (en) Amorphous (r)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2- pyridinyl]methyl]sulfinyl]-1h-benzimidazole as anti-ulcer agent
HUP9603014A2 (hu) Savas közegben bomlékony benzimidazolszármazékot tartalmazó új, stabilizált galenusi gyógyszerkészítmények és előállításuk
MEP7808A (en) Process for preparing 4-trifluoromethylsulphinylpyrazole derivative
EP0997461A4 (en) PROCESSES FOR THE PREPARATION OF PYRIDINIC DERIVATIVES
CA2387746A1 (en) Methods for stabilizing benzimidazole-based compounds
FI99112C (fi) Menetelmä terapeuttisesti käyttökelpoisten bentsimidatsolijohdannaisten valmistamiseksi
WO2000047584A3 (de) Epothilon-derivate, verfahren zu deren herstellung und ihre pharmazeutische verwendung
ATE216382T1 (de) Verfahren zur herstellung von 5-methoxy-2-((4- methoxy-3,5-dimethyl-2-pyrydyl)methyl)sulfinyl- h-benzimidazol
IL155181A0 (en) A process for the preparation of pantoprazole and intermediates therefor
YU47605B (sh) Postupak za dobijanje supstituisanih derivata stirena
YU59401A (sh) Postupak za proizvodnju alendronske kiseline
ATE272686T1 (de) Verfahren zur herstellung von triphendioxazinpigmenten
WO1999033807A3 (en) Synthesis of pharmaceutically useful pyridine derivatives (intermediates) employing free radical substitution reactions to functionalize the 2-position of the pyridine
KR100573705B1 (ko) 설파이드 유도체의 제조 방법
DE60239324D1 (de) Phenyl- und pyridyl-piperidine mit tnf-wirkung
ATE333444T1 (de) Neues verfahren zur herstellung von 1-phenyl-2-(2-pyridyl)ethanamin
AU2003213386A1 (en) Process for production of optically active compounds
ATE191911T1 (de) Neue chinoloncarbonsäurederivate

Legal Events

Date Code Title Description
FG Grant or registration